Artículos por temáticas

Movement disorders on YouTube--caveat spectator.

Stamelou M, Edwards MJ, Espay AJ, Fung VS, Hallett M, Lang AE, Tijssen MA, Bhatia KP.

N Engl J Med. 2011 Sep 22;365(12):1160-1. doi: 10.1056/NEJMc1107673. No abstract available.

[Drug induced movement disorders: role of antipsychotic drugs].

Damásio J, Carvalho S.

Acta Med Port. 2011 Dec;24 Suppl 4:915-22. Review. Portuguese.

Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Caroff SN, Hurford I, Lybrand J, Campbell EC.

Neurol Clin. 2011 Feb;29(1):127-48, viii. doi: 10.1016/j.ncl.2010.10.002.

What is the role of genetic testing in movement disorders practice?

Schneider SA, Klein C.

Curr Neurol Neurosci Rep. 2011 Aug;11(4):351-61. doi: 10.1007/s11910-011-0200-4. Review.

Drug-induced hyperkinetic movement disorders by nonneuroleptic agents.

Zesiewicz TA, Sullivan KL.

Handb Clin Neurol. 2011;100:347-63. doi: 10.1016/B978-0-444-52014-2.00027-6. Review.

The movement disorder society and movement disorders: a modern history.

Goetz CG, McGhiey A.

Mov Disord. 2011 May;26(6):939-46. doi: 10.1002/mds.23689. Review.

How psychogenic" are psychogenic movement disorders?"

Stone J, Edwards MJ.

Mov Disord. 2011 Aug 15;26(10):1787-8. doi: 10.1002/mds.23882. No abstract available.

Movement disorders in spinocerebellar ataxias.

Pedroso JL, Felicio AC, Braga-Neto P, Barsottini OG.

Mov Disord. 2011 Oct;26(12):2302. doi: 10.1002/mds.23928. No abstract available.

Review and update of involuntary facial movement disorders presenting in the ophthalmological setting.

Ross AH, Elston JS, Marion MH, Malhotra R.

Surv Ophthalmol. 2011 Jan-Feb;56(1):54-67. doi: 10.1016/j.survophthal.2010.03.008. Review.

Is the time ripe to adopt semiquantitative analysis of SPECT evaluation in movement disorders as a standard?

Caobelli F, Paghera B, Giubbini R.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):596-7. doi: 10.1007/s00259-010-1709-5. No abstract available.

Analysis of hemorrhagic risk factors during deep brain stimulation surgery for movement disorders: comparison of the circumferential paired and multiple electrode insertion methods.

Park JH, Chung SJ, Lee CS, Jeon SR.

Acta Neurochir (Wien). 2011 Aug;153(8):1573-8. doi: 10.1007/s00701-011-0997-2.

The case for subspecialization in neurology: movement disorders.

Farbman ES.

Front Neurol. 2011 Apr 12;2:22. doi: 10.3389/fneur.2011.00022. No abstract available.

Milestones in movement disorders clinical trials: advances and landmark studies.

Olanow CW, Wunderle KB, Kieburtz K.

Mov Disord. 2011 May;26(6):1003-14. doi: 10.1002/mds.23727. Review.

Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.

Merello M, Gerschcovich ER, Ballesteros D, Cerquetti D.

Parkinsonism Relat Disord. 2011 Nov;17(9):705-7. doi: 10.1016/j.parkreldis.2011.07.002.

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.

Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ.

J Neuroimmunol. 2011 Dec 15;240-241:121-8. doi: 10.1016/j.jneuroim.2011.10.005.